Journal
CELL METABOLISM
Volume 21, Issue 1, Pages 117-125Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2014.11.020
Keywords
-
Categories
Funding
- CPRIT [RP101496]
- ACS Award [13-068-01-TBG]
- Lung Cancer SPORE [P50CA70907]
- European Commission [CIG 320898, ERC-Consolidator 614847]
- Swiss National Science Foundation [310030_146533/1]
- Louis-Jeantet Foundation
- Swiss National Science Foundation (SNF) [310030_146533] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Dietary effects on tumor biology can be exploited to unravel cancer vulnerabilities. Here, we present surprising evidence for anti-proliferative action of high-calorie-diet (HCD) feeding on KRAS-driven lung tumors. Tumors of mice that commenced HCD feeding before tumor onset displayed defective unfolded protein response (UPR) and unresolved endoplasmic reticulum (ER) stress. Unresolved ER stress and reduced proliferation are reversed by chemical chaperone treatment. Whole-genome transcriptional analyses revealed FKBP10 as one of the most downregulated chaperones in tumors of the HCD-pre-tumor-onset group. FKBP10 downregulation dampens tumor growth in vitro and in vivo. Providing translational value to these results, we report that FKBP10 is expressed in human KRAS-positive and -negative lung cancers, but not in healthy parenchyma. Collectively, our data shed light on an unexpected anti-tumor action of HCD imposed before tumor onset and identify FKBP10 as a putative therapeutic target to selectively hinder lung cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available